$24.31
-0.36 (-1.44%)

Key Metrics

Market Cap
$138.19B
P/E Ratio
12.86
EPS
$1.89
Beta
N/A
Dividend Yield
N/A
ROE
11.96%
Current Ratio
1.16

Company Information

Industry
Drug Manufacturers General

About Pfizer Inc

Pfizer Inc discovers develops manufactures markets distributes and sells biopharmaceutical products worldwide It offers medicines and vaccines in various therapeutic areas including cardiovascular metabolic and womens health under the Premarin family and Eliquis brands biologics small molecules immunotherapies and biosimilars under the Ibrance Xtandi Sutent Inlyta Retacrit Lorbrena and Braftovi brands and sterile injectable and antiinfective medicines and oral COVID19 treatment under the Sulperazon Medrol Zavicefta Zithromax Vfend Panzyga and Paxlovid brands The company also provides medicines and vaccines in various therapeutic areas such as pneumococcal disease meningococcal disease tickborne encephalitis and COVID19 under the ComirnatyBNT162b2 Nimenrix FSMEIMMUNTicoVac Trumenba and the Prevnar family brands biosimilars for chronic immune and inflammatory diseases under the Xeljanz Enbrel Inflectra EucrisaStaquis and Cibinqo brands and amyloidosis hemophilia and endocrine diseases under the VyndaqelVyndamax BeneFIX and Genotropin brands In addition the company is involved in the contract manufacturing business It serves wholesalers retailers hospitals clinics government agencies pharmacies and individual provider offices as well as disease control and prevention centers The company has collaboration agreements with BristolMyers Squibb Company Astellas Pharma US Inc Myovant Sciences Ltd Akcea Therapeutics Inc Merck KGaA Valneva SE BioNTech SE and Arvinas Inc Pfizer Inc was founded in 1849 and is headquartered in New York New York

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-11-04 $0.87 $0.63 +37.4%
2025-08-05 $0.78 $0.58 +34.5%
2025-04-29 $0.92 $0.67 +38.1%
2025-02-04 $0.63 $0.47 +33.6%

Financial Ratios (TTM)

Gross Margin
67.34%
Operating Margin
29.60%
Net Margin
16.85%
ROA
5.22%
Price to Book
1.58
Price to Sales
2.20